In preclinical models, the aryl hydrocarbon receptor (AHR) ligand indole-3-carbinole (I3C), or breast milk administration, leads to the activation of AHR ligands, resulting in reduced TLR4 signaling and decreased NEC in newborn mice [84]. Here, TLR4 is linked to necrotizing enterocolitis.